SCHEMBL24153265

SCHEMBL24153265

CCCCN1C(=O)/C(=C/c2nccs2)c2cc(S(=O)(=O)N(CCCC)Cc3ccc(F)cc3F)ccc21

nearest known ligand 0.37

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ TRPA1 O75762 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ CASP3 P42574 12/20 0.34
▸ CASP7 P55210 9/20 0.34
▸ TAS2R14 Q9NYV8 1/20 0.33
▸ LMNA P02545 1/20 0.32
▸ MAOA P21397 3/20 0.32
▸ MAOB P27338 2/20 0.32
▸ TP53 P04637 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ BRD4 O60885 1/20 0.31
▸ CASP1 P29466 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24152819 0.93 RXFP1 (0.34) TRPA1RXFP1KDM4ECASP3TAS2R14
SCHEMBL24151572 0.91 CASP3 (0.41) TRPA1RXFP1CASP3CASP7MAOA
SCHEMBL24153256 0.88 TRPA1 (0.37) TRPA1KDM4ECASP3CASP7TAS2R14
SCHEMBL24152825 0.84 TAS2R14 (0.35) TRPA1KDM4ECASP3TAS2R14LMNA
SCHEMBL24153267 0.83 TRPA1 (0.48) TRPA1CASP3CASP7TAS2R14MAOA
SCHEMBL24153270 0.83 TRPA1 (0.39) TRPA1KDM4ECASP3CASP7TAS2R14
SCHEMBL24152818 0.83 TRPA1 (0.34) TRPA1KDM4ECASP3TAS2R14LMNA
SCHEMBL24152504 0.83 TAS2R14 (0.41) TRPA1KDM4ECASP3TAS2R14LMNA
SCHEMBL24152493 0.83 PTGS1 (0.37) TRPA1KDM4ECASP3TAS2R14LMNA
SCHEMBL24152352 0.81 MAOA (0.41) TRPA1RXFP1KDM4ECASP3TAS2R14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021260722-A1 DESIGN, SYNTHESIS OF NOVEL OXYINDOLE INHIBITORS OF DENV RNA DEPENDENT RNA POLYMERASE TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE (IN) 2021-12-30 — — WO disclosed
Send feedback